Foreign-invested pharmaceutical firms turn to aggressive marketing

Foreign-invested pharmaceutical firms are employing aggressive marketing tactics in a bid to take the leading position in the domestic pharmaceutical market within thee years with their new products.

Janssen Korea is hoping to take the first position with three new products including Triclest (oral contraceptive) and Ultracet (pain killer) in 2005 among foreign-invested pharmaceutical firms...